Brain Advance Access originally published online on September 4, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 126, No. 12, 2750-2760,
December 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg284
Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine
1 Centre for Functional Magnetic Resonance Imaging of the Brain, The John Radcliffe Hospital, 2 Russell-Cairns Unit, Radcliffe Infirmary and 3 Department of Neurology, The Radcliffe Infirmary, UK
Correspondence to: Professor Paul Matthews, Centre for Functional Magnetic Resonance Imaging of the Brain, The John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK E-mail: paul{at}fmrib.ox.ac.uk
One explanation for the weak relationship between neuropsychological deficits and conventional measures of disease burden in multiple sclerosis is that brain ‘plasticity’ allows adaptive reorganization of cognitive functions to limit impairment, despite injury. We have tested this hypothesis. Ten patients with multiple sclerosis and 11 healthy controls were studied using a functional MRI (fMRI) counting Stroop task. The two subject groups had comparable performances, but a predominantly left medial prefrontal region [Brodmann area (BA) 8/9/10] was more active during the task in patients than in controls (corrected P < 0.001), while a right frontal region (including BA 45 and the basal ganglia) was more active in controls than in patients (corrected P = 0.004). The magnitude of the differences correlated with the normalized brain parenchymal volume, a measure of disease burden (r = –0.72, P = 0.02). We then tested the effects of acute administration of rivastigmine, a central cholinesterase inhibitor, on patterns of brain activation. In five out of five multiple sclerosis patients there was a relative normalization of the abnormal Stroop-associated brain activation, although no change in the patterns of brain activation was found in any of four healthy controls given the drug and tested in the same way. We suggest that recruitment of medial prefrontal cortex is a form of adaptive brain plasticity that compensates, in part, for relative deficits in processing related to the reduced right prefrontal cortex activity with multiple sclerosis. This functional plasticity is modulated by cholinergic agonism and must arise from potentially highly dynamic mechanisms such as the ‘unmasking’ of latent pathways.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Prakash, E. Snook, J. Lewis, R. Motl, and A. Kramer Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis Multiple Sclerosis, November 1, 2008; 14(9): 1250 - 1261. [Abstract] [PDF]
|
|
|
|
|
|
P Nilsson, I Rorsman, E. Larsson, B Norrving, and M Sandberg-Wollheim Cognitive dysfunction 24-31 years after isolated optic neuritis Multiple Sclerosis, August 1, 2008; 14(7): 913 - 918. [Abstract] [PDF]
|
|
|
|
|
|
B Audoin, F Reuter, M. Duong, I Malikova, S Confort-Gouny, A. Cherif, P. Cozzone, J Pelletier, and J. Ranjeva Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study Multiple Sclerosis, July 1, 2008; 14(6): 786 - 792. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Dutta and B. D. Trapp Pathogenesis of axonal and neuronal damage in multiple sclerosis Neurology, May 29, 2007; 68(22_suppl_3): S22 - S31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Bobholz, S. M. Rao, L. Lobeck, C. Elsinger, A. Gleason, J. Kanz, S. Durgerian, and E. Maas fMRI study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume. Neurology, November 14, 2006; 67(9): 1640 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wegner, M. M. Esiri, S. A. Chance, J. Palace, and P. M. Matthews Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology, September 26, 2006; 67(6): 960 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Goekoop, P. Scheltens, F. Barkhof, and S. A. R. B. Rombouts Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study Brain, January 1, 2006; 129(1): 141 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pantano, C. Mainero, D. Lenzi, F. Caramia, G. D. Iannetti, M. C. Piattella, I. Pestalozza, S. Di Legge, L. Bozzao, and C. Pozzilli A longitudinal fMRI study on motor activity in patients with multiple sclerosis Brain, September 1, 2005; 128(9): 2146 - 2153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D'Intino, M. Paradisi, M. Fernandez, A. Giuliani, L. Aloe, L. Giardino, and L. Calza Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats PNAS, February 22, 2005; 102(8): 3070 - 3075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Filippi and M A Rocca Cortical reorganisation in patients with MS J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1087 - 1089. [Full Text] [PDF]
|
|